Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 May;53(5):1458–1467. doi: 10.1172/JCI107694

Assay of Total Plasma Apolipoprotein B Concentration in Human Subjects

Gustav Schonfeld 1, Robert S Lees 1, P K George 1, Barbara Pfleger 1
PMCID: PMC302634  PMID: 4363408

Abstract

We have developed a double antibody radioimmunoassay (RIA) for human apolipoprotein B (ApoB). The assay measures not only the ApoB content of β-lipoproteins (low density lipoproteins [LDL]) but also that contained in the other lipoproteins in plasma.

Purified lymph and plasma chylomicrons and plasma very low density lipoproteins (VLDL) produced displacement curves in the assay system which paralleled those produced by pure LDL. Thus, the ApoB found in chylomicrons, VLDL, and LDL were immunologically identical. ApoB accounted for about 25 and 35%, respectively, of the total protein of chylomicrons and VLDL by RIA. VLDL and LDL preparations from normal and hyperlipoproteinemic subjects also produced parallel displacement curves, suggesting that the ApoB of normal and hyperlipoproteinemic subjects were immunologically identical. High density lipoproteins and abetalipoproteinemic plasma displaced no counts, nor did the sera of several animal species produce any useful displacement curves in this system.

The fasting total plasma ApoB concentration of normal subjects was 83±16 mg/dl (mean±SD). ApoB levels were high in Type II (162±16), and less so in Type IV (112±24) and Type V (105±17).

When plasma ApoB concentration in Type IV patients was graphed against plasma glycerides, two subpopulations, which may represent different genetic or biochemical subgroups, were apparent.

ApoB concentration in individuals on constant diet and drug regimen was stable over weeks to months. Greater than 90% of ApoB of normal and Type II subjects was in the d > 1.006 plasma fraction. By contrast, only 50-80% of ApoB was in the d > 1.006 fraction in Types IV and V. Thus, hypertriglyceridemia was associated primarily with a redistribution of ApoB to the lighter density fractions; by contrast, in hypercholesterolemia absolute ApoB concentration was markedly increased.

Full text

PDF
1459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alaupovic P., Kostner G., Lee D. M., McConathy W. J., Magnani H. N. Peptide composition of human plasma apolipoproteins A, B and C. Expos Annu Biochim Med. 1972;31:145–160. [PubMed] [Google Scholar]
  2. Barter P. J., Nestel P. J. Precursor-product relationship between pools of very low density lipoprotein triglyceride. J Clin Invest. 1972 Jan;51(1):174–180. doi: 10.1172/JCI106789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  4. Brown W. V., Levy R. I., Fredrickson D. S. Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem. 1969 Oct 25;244(20):5687–5694. [PubMed] [Google Scholar]
  5. CARLSON L. A. DETERMINATION OF SERUM TRIGLYCERIDES. J Atheroscler Res. 1963 Jul-Aug;3:334–336. doi: 10.1016/s0368-1319(63)80012-5. [DOI] [PubMed] [Google Scholar]
  6. Eaton R. P., Kipnis D. M. Incorporation of Se75 selenomethionine into a protein component of plasma very-low-density lipoprotein in man. Diabetes. 1972 Jun;21(6):744–753. doi: 10.2337/diab.21.6.744. [DOI] [PubMed] [Google Scholar]
  7. Eaton R. P., Kipnis D. M. Radioimmunoassay of beta lipoprotein-protein of rat serum. J Clin Invest. 1969 Aug;48(8):1387–1396. doi: 10.1172/JCI106104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ehnholm C., Garoff H., Renkonen O., Simons K. Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma. Biochemistry. 1972 Aug 15;11(17):3229–3232. doi: 10.1021/bi00767a015. [DOI] [PubMed] [Google Scholar]
  9. FREDRICKSON D. S., LEES R. S. A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA. Circulation. 1965 Mar;31:321–327. doi: 10.1161/01.cir.31.3.321. [DOI] [PubMed] [Google Scholar]
  10. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 26;276(4):215–contd. doi: 10.1056/NEJM196701262760406. [DOI] [PubMed] [Google Scholar]
  11. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goodman D. S., Noble R. P. Turnover of plasma cholesterol in man. J Clin Invest. 1968 Feb;47(2):231–241. doi: 10.1172/JCI105719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gotto A. M., Brown W. V., Levy R. I., Birnbaumer M. E., Fredrickson D. S. Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J Clin Invest. 1972 Jun;51(6):1486–1494. doi: 10.1172/JCI106945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gotto A. M., Jr Recent studies on the structure of human serum low-and high-density lipoproteins. Proc Natl Acad Sci U S A. 1969 Nov;64(3):1119–1127. doi: 10.1073/pnas.64.3.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hatch F. T. Practical methods for plasma lipoprotein analysis. Adv Lipid Res. 1968;6:1–68. [PubMed] [Google Scholar]
  17. Hurley P. J., Scott P. J. Plasma turnover of Sf 0-9 low-density lipoprotein in normal men and women. Atherosclerosis. 1970 Jan-Feb;11(1):51–76. doi: 10.1016/0021-9150(70)90007-9. [DOI] [PubMed] [Google Scholar]
  18. Kahan J., Sundblad L. Immunochemical determination of beta-lipoproteins. Scand J Clin Lab Invest. 1969 Aug;24(1):61–68. doi: 10.3109/00365516909080133. [DOI] [PubMed] [Google Scholar]
  19. Kane J. P., Richards E. G., Havel R. J. Subunit heterogeneity in human serum beta lipoprotein. Proc Natl Acad Sci U S A. 1970 Aug;66(4):1075–1082. doi: 10.1073/pnas.66.4.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kostner G., Holasek A. Characterization and quantitation of the apolipoproteins from human chyle chylomicrons. Biochemistry. 1972 Mar 28;11(7):1217–1223. doi: 10.1021/bi00757a016. [DOI] [PubMed] [Google Scholar]
  21. LEES R. S., HATCH F. T. Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J Lab Clin Med. 1963 Mar;61:518–528. [PubMed] [Google Scholar]
  22. Lee D. M., Alaupovic P. Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry. 1970 May 26;9(11):2244–2252. doi: 10.1021/bi00813a004. [DOI] [PubMed] [Google Scholar]
  23. Lees R. S. Immunoassay of plasma low-density lipoproteins. Science. 1970 Jul 31;169(3944):493–495. doi: 10.1126/science.169.3944.493. [DOI] [PubMed] [Google Scholar]
  24. Lees R. S., Wilson D. E., Schonfeld G., Fleet S. The familial dyslipoproteinemias. Prog Med Genet. 1973;9:237–290. [PubMed] [Google Scholar]
  25. Levy R. I., Bilheimer D. W., Eisenberg S. The structure and metabolism of chylomicrons and very low density lipoproteins (VLDL). Biochem Soc Symp. 1971;(33):3–17. [PubMed] [Google Scholar]
  26. Margolis S., Langdon R. G. Studies on human serum beta-1-lipoprotein. I. Amino acid composition. J Biol Chem. 1966 Jan 25;241(2):469–476. [PubMed] [Google Scholar]
  27. Midgley A. R., Jr, Niswender G. D., Rebar R. W. Principles for the assessment of the reliability of radioimmunoassay methods (precision, accuracy, sensitivity, specificity). Acta Endocrinol Suppl (Copenh) 1969;142:163–184. doi: 10.1530/acta.0.062s163. [DOI] [PubMed] [Google Scholar]
  28. Nikkilä E. A., Kekki M. Measurement of plasma triglyceride turnover in the study of hyperglyceridemia. Scand J Clin Lab Invest. 1971 Apr;27(2):97–104. doi: 10.3109/00365517109080194. [DOI] [PubMed] [Google Scholar]
  29. Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
  30. Oncley J. L., Harvie N. R. Lipoproteins--a current perspective of methods and concepts. Proc Natl Acad Sci U S A. 1969 Nov;64(3):1107–1118. doi: 10.1073/pnas.64.3.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Reaven G. M., Hill D. B., Gross R. C., Farquhar J. W. Kinetics of triglyceride turnover of very low density lipoproteins of human plasma. J Clin Invest. 1965 Nov;44(11):1826–1833. doi: 10.1172/JCI105290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rudman D., Garcia L. A., Howard C. H. A new method for isolating the nonidentical protein subunits of human plasma alpha-lipoprotein. J Clin Invest. 1970 Feb;49(2):365–372. doi: 10.1172/JCI106245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Scanu A. M., Wisdom C. Serum lipoproteins structure and function. Annu Rev Biochem. 1972;41:703–730. doi: 10.1146/annurev.bi.41.070172.003415. [DOI] [PubMed] [Google Scholar]
  34. Scanu A., Toth J., Edelstein C., Koga S., Stiller E. Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity. Biochemistry. 1969 Aug;8(8):3309–3316. doi: 10.1021/bi00836a027. [DOI] [PubMed] [Google Scholar]
  35. Schreibman P. H., Wilson D. E., Arky R. A. Familial type IV hyperlipoproteinemia. N Engl J Med. 1969 Oct 30;281(18):981–985. doi: 10.1056/NEJM196910302811803. [DOI] [PubMed] [Google Scholar]
  36. Seidel D., Alaupovic P., Furman R. H., McConathy W. J. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest. 1970 Dec;49(12):2396–2407. doi: 10.1172/JCI106459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shore B., Shore V. Isolation and characterization of polypeptides of human serum lipoproteins. Biochemistry. 1969 Nov;8(11):4510–4516. doi: 10.1021/bi00839a043. [DOI] [PubMed] [Google Scholar]
  38. Wilson D. E., Lees R. S. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J Clin Invest. 1972 May;51(5):1051–1057. doi: 10.1172/JCI106896. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES